Company: TVRD
Filing Date: 2025-01-27
Form Type: S-4/A
Source: 0001104659-25-006050
Chunk: 795

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-27
Form: S-4/A
Chunk 795
---
 settled in shares of the Company’s common stock (see Note 15, Stock-Based Compensation ). In February and March 2021, as a result of the achievement of certain performance targets, an aggregate of 6,396 performance-based restricted stock units of various executive officers vested and were settled in shares of the Company’s common stock (see Note 15, Stock-Based Compensation ). In February 2021, as a result of the completion of the first year of the three-year vesting period, an aggregate of 2,722 time-based restricted stock units of various executive officers vested and were settled in shares of the Company’s common stock (see Note 15, Stock-Based Compensation ).

<div align='center'>F-61</div>

CARA THERAPEUTICS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (amounts in thousands, except share and per share data)

12. Fair Value Measurements

The following tables summarize the Company’s financial assets measured at fair value on a recurring basis as of December 31, 2023 and 2022, and by level within the fair value hierarchy:

Fair value measurement as of December 31, 2023:

Financial assets

| ​                                         
 ​                                         
 ​                                         
 ​                                         
 Type of Instrument                        
 Cash and cash equivalents:                | ​ 
 ​ 
 ​ 
 ​ | ​     
 ​     
 ​     
 ​     
 Total 
 ​     |       ​ 
       ​ 
       ​ 
       ​ | ​ 
 ​ 
 ​ 
 ​ | ​                  
 Quoted prices in   
 active markets for 
 identical assets   
 (Level 1)          
 ​                  |      ​ | ​ 
 ​ 
 ​ 
 ​ | ​                 
 Significant other 
 observable        
 inputs            
 (Level 2)         
 ​                 |      ​ | ​ 
 ​ 
 ​ 
 ​ | ​            
 Significant  
 unobservable 
 inputs       
 (Level 3)    
 ​            | ​ |
|:------------------------------------------|:--|:------|--------:|:--|:-------------------|-------:|:--|:------------------|-------:|:--|:-------------|:--|
| Money market funds and checking accounts  | ​ | $     |  51,775 | ​ | $                  | 51,775 | ​ | $                 |      — | ​ | $            | — |
| Available-for-sale marketable securities: | ​ |       |       ​ | ​ |                    |        | ​ |                   |      ​ | ​ |